Aspen Institute

---

Work on the development of a vaccine against coronavirus

still While The World you'd expect to worry about the spread of the deadly coronavirus, now known as Covid-19, that the big pharmaceutical companies make millions, even billions, of rushing to develop a vaccine.

But in reality, this is not the case. While the global vaccine market is expected to grow to $60bn (£46bn) are not guaranteed in this year's big gains.

"is Successful, the development of a preventive vaccine or treatment for a Public Health crisis, difficult. Normally it takes a lot of time and money," says US-based Brad Loncar, a biotechnology investor and chief executive of Loncar investments.

"It is usually little money in it for companies that successfully develop something, not the billions, expect some investors mistakenly. "

The global vaccines industry is dominated by large players, such as Pfizer, Merck, GlaxoSmithKline (GSK), Sanofi-Aventis, and Johnson & Johnson.

the Global sales of vaccines amounted to $54bn last year, and almost doubled since 2014, according to data analysts at Statista. The drivers of this growth are the increase in infectious diseases such as influenza, swine flu, hepatitis, and Ebola is.

The Corona-Virus outbreak is think by far the contained

"would that the industry has the reserves to jump on this challenge. But none of The Four top-vaccine-company has shown significant interest," says Dr. Ellen 't Hoen, Executive Director medicines law and policy at the University Medical Center Groningen in Amsterdam.

Outside of the big companies, there are a handful of smaller pharmaceutical companies, at the urging of you to find a vaccine for the deadly Covid-19-outbreak that has already claimed More Than 1,000 lives.

of Gilead, a US biotech business that makes anti-HIV drugs, has announced that it will be the trial drug. Meanwhile, a combination of two anti-HIV drugs from the pharmaceutical company AbbVie is to be tested on patients in China. Both studies are based on existing drugs.

"A large company like Gilead or AbbVie will be able to, an existing medicine against them as a therapeutic treatment, but it is unlikely to be much of a needle mover from an exchange perspective for a large company like that," adds Mr. Loncar.

There is no guarantee that a pharmaceutical would make the company a lot of money from the vaccine

For Covid-19, donations will be used to find sparks pharmaceutical company in a vaccine. One of the leading players is a not-for-profit organization with the name (CEPI).

CEPI co-founder, the governments of Norway and India, The Bill and Melinda Gates Foundation and the Wellcome Trust . CEPI support the vaccine-development programs by Inovio Pharmaceuticals and Moderna is.

Among The Major pharmaceutical companies, GSK has pledged its technology available to the CEPI to help, it is a medicine against Covid-19.

vaccines often require time-consuming Tests on thousands of people before they are allowed to be sold. But in the years 2002 and 2003, the Sars outbreak came and went, before a vaccine could be produced. In fact, there is still no protective vaccine against Sars available.

in terms of Ebola , The First vaccine was made by Merck, and successfully used in Guinea, West Africa , in the year 2015. At the time it was a non-licensed drug, but it was rolled out in the country for "compassionate use" after the approval of the Guinean government. The Merck vaccine was not given, the regulatory approval in the United States until last year.

Another Ebola vaccine from Johnson & Johnson was made available starting in 2019, the Democratic Republic of the Congo.

Ronald Klain served as U.S. Ebola response coordinator in 2014-15. "I don't work for the company, I'm like a drug, company fan," Mr. Klain to a panel last week hosted by " not-for-profit think-tank, the Aspen Institute said, "but there is no question that many of them are trying to lost a lot of money to produce an Ebola vaccine. "

Merck Ebola -virus-vaccine-took five years to develop

A major reason why vaccines often have to wait years before you is the approval of the authorities, the potential for Side Effects . This can also happen even if a drug has been approved.

During the 2009-10 swine flu pandemic, six million people vaccine from GlaxoSmithKline were given the Pandemrix. However, it was taken in the result of the sale, after it was discovered that the cause of narcolepsy in some people. Narcolepsy is a sleep disorder that causes people to fall asleep several times A Day .

the talk in the last week in Aspen Institute event, Dr. Anthony Fauci, Director of the US National Institute of Allergy and infectious diseases, said that without a large pharmaceutical company has come forward to say it would be the production of a vaccine for Covid-19. He called it a "very difficult and very frustrating".

"the companies have the skills to do in the situation, not just sit around and go to a warm décor, ready for when you need it," Dr. Fauci said.

world trade

added the

Dr. Fauci, that there is a Covid-19 vaccine would take at least a year before available. This timeline goes from a major pharmaceutical to help manufacturers make The Product . The World Health organization (WHO) hopes that a vaccine to be ready within 18 months.

the pharmaceutical companies have responded to previous crises of Public Health through the development of vaccines, only to have these crises fade and be left with significant costs for research and development. "If we do this with Ebola , it was a big vaccine company was burned, and who now," says Dr. Fauci. "It is a challenge to be able to do a great company. "

Mr. Loncar sums up the mentality of the large pharmaceutical companies, as he said, "most companies and investors are not in these things for long".

pharmaceutical industry, coronavirus outbreak, public health, bill gates, vaccination, medicine, ebola treatments

Source of news: bbc.com